Does EXEMESTANE Cause Malignant neoplasm progression? 1,025 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,025 reports of Malignant neoplasm progression have been filed in association with EXEMESTANE (Exemestane). This represents 9.8% of all adverse event reports for EXEMESTANE.
1,025
Reports of Malignant neoplasm progression with EXEMESTANE
9.8%
of all EXEMESTANE reports
144
Deaths
148
Hospitalizations
How Dangerous Is Malignant neoplasm progression From EXEMESTANE?
Of the 1,025 reports, 144 (14.0%) resulted in death, 148 (14.4%) required hospitalization, and 26 (2.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EXEMESTANE. However, 1,025 reports have been filed with the FAERS database.
What Other Side Effects Does EXEMESTANE Cause?
Fatigue (1,122)
Arthralgia (943)
Diarrhoea (941)
Nausea (913)
Neoplasm progression (692)
Dyspnoea (673)
Malaise (620)
Headache (606)
Asthenia (597)
Breast cancer metastatic (591)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which EXEMESTANE Alternatives Have Lower Malignant neoplasm progression Risk?
EXEMESTANE vs EXENATIDE
EXEMESTANE vs EXFORGE
EXEMESTANE vs EXJADE
EXEMESTANE vs EXTAVIA
EXEMESTANE vs EXTRANEAL